Lobeglitazone | CAS 607723-33-1 - Request Quote
Lobeglitazone
| SZ CAT No: | SZ-L079005 |
| CAS No | 607723-33-1 |
| Mol.F. | C24H24N4O5S |
| Mol.Wt. | 480.5 |
| Inv. Status | In Stock |
| Rel. CAS No | 763108-62-9 (sulfate salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lobeglitazone is chemically 5-(4-(2-((6-(4-Methoxyphenoxy)pyrimidin-4-yl)(methyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione. Lobeglitazone is supplied with detailed characterization data compliant with regulatory guideline. Lobeglitazone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lobeglitazone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 607723-33-1
Purchase 607723-33-1
Order 607723-33-1
Enquire 607723-33-1
price of 607723-33-1
607723-33-1 Supplier
607723-33-1 Manufacturer
607723-33-1 Exporter
buy high quality Lobeglitazone
Purchase Lobeglitazone
Lobeglitazone suppliers
Lobeglitazone manufacturers
Lobeglitazone price
Order Lobeglitazone
Enquire Lobeglitazone
Lobeglitazone cost
Lobeglitazone Supplier
Lobeglitazone Distributor
Lobeglitazone for Method Validation
Lobeglitazone Reference Standard
Lobeglitazone for ANDA Filing
Lobeglitazone for Forced Degradation Studies
Lobeglitazone Identification Standards
Lobeglitazone for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.